MeSH D010538 - peritonitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ceftriaxone | Ceftriaxone |  | 2007-03-15 |  |  |
| Mylan | Cefoxitin | Mefoxin |  | 1987-01-08 |  |  |
| Roche | Ceftriaxone, Lidocaine | Rocephin |  | 1985-03-12 | $261.442 M | Y2021 |
| Lupin Research | Cefotaxime | Cefotaxime |  | 2003-09-24 |  |  |
| Ceftriaxone | Ceftriaxone |  | 2003-09-30 |  |  | |
| Sandoz | Ceftriaxone | Ceftriaxone |  | 2005-05-17 |  |  |
| Meropenem | Meropenem |  | 2011-03-29 |  |  | |
| Sanofi | Cefotaxime | Claforan |  | 1987-01-13 |  |  |
| Merck & Co | Cefoxitin | Mefoxin |  | 1984-09-20 |  |  |
| Pfizer | Anidulafungin | Ecalta |  | 2007-09-20 |  |  |
| Meropenem | Merrem |  | 1996-06-21 |  |  | |
| Aurobindo Pharma | Cefotaxime | Cefotaxime |  | 2009-11-06 |  |  |
| Ceftriaxone | Ceftriaxone |  | 2008-07-31 |  |  | |
| Hospira | Cefotaxime | Cefotaxime |  | 2006-08-11 |  |  |
| Cefoxitin | Cefoxitin |  | 2006-02-13 |  |  | |
| Ceftriaxone | Ceftriaxone |  | 2005-08-02 |  |  | |
| Meropenem | Meropenem |  | 2010-06-22 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
67%8/12
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use